Spinal injection trial begins for new Alzheimer's hope
NCT ID NCT07234942
Summary
This is the first human study of an experimental drug called RO7812653 for early Alzheimer's disease. The main goal is to check if the drug is safe and well-tolerated when given as a single injection into the spinal fluid. The study will enroll about 50 participants with early memory problems to monitor for side effects and see how the drug moves through the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brain Research Center Amsterdam
RECRUITINGAmsterdam, North Holland, 1081 HV, Netherlands
-
National Hospital For Neurology and Neurosurgery
RECRUITINGLondon, WC1N 3BG, United Kingdom
Conditions
Explore the condition pages connected to this study.